VOLORIDGE INVESTMENT MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2020$716,000
-66.6%
8,174
-60.1%
0.02%
-50.0%
Q4 2019$2,142,000
+1.0%
20,483
+11.1%
0.04%
+13.5%
Q3 2019$2,120,000
+387.4%
18,430
+630.2%
0.04%
+208.3%
Q2 2019$435,000
-90.2%
2,524
-90.4%
0.01%
-91.0%
Q1 2019$4,441,000
-17.6%
26,346
-31.8%
0.13%
-6.9%
Q2 2018$5,389,000
+525.2%
38,623
+349.2%
0.14%
+585.7%
Q2 2017$862,000
-84.4%
8,598
-81.1%
0.02%
-84.3%
Q1 2017$5,516,000
+38.5%
45,608
+28.0%
0.13%
+55.8%
Q4 2016$3,982,00035,6290.09%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2017
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders